12 Health Care Stocks Moving In Monday's After-Market Session

週一盤後交易時段，12只醫療保健股走勢

Benzinga · 2023/11/21 05:31

NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of its average volume over the last 100 days. The company's market cap stands at $57.8 million.
TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 11.24% to $0.58. At the close, TC BioPharm (Holdings)'s trading volume reached 265.9K shares. This is 294.2% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.
Nemaura Medical (NASDAQ:NMRD) shares rose 8.08% to $0.26. The company's market cap stands at $7.3 million.
Exagen (NASDAQ:XGN) stock moved upwards by 7.54% to $1.71. The market value of their outstanding shares is at $28.9 million.
NanoVibronix (NASDAQ:NAOV) shares rose 6.92% to $1.39. The market value of their outstanding shares is at $6.3 million.
Allarity Therapeutics (NASDAQ:ALLR) stock rose 6.0% to $0.53. The market value of their outstanding shares is at $2.2 million. As per the press release, Q3 earnings came out 4 days ago.

Alzamend Neuro (NASDAQ:ALZN) shares decreased by 19.4% to $1.12 during Monday's after-market session. Alzamend Neuro's trading volume hit 2.7 million shares by close, accounting for 13294.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
Gain Therapeutics (NASDAQ:GANX) shares fell 16.37% to $2.3. The company's market cap stands at $29.2 million. As per the news, the Q3 earnings report came out 4 days ago.
Acutus Medical (NASDAQ:AFIB) shares declined by 16.04% to $0.29. Today's trading volume for this security ended up closing at 399.7K shares, which is 117.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
AVITA Medical (NASDAQ:RCEL) shares declined by 11.2% to $11.11. The market value of their outstanding shares is at $283.8 million.
Vicarious Surgical (NYSE:RBOT) stock decreased by 10.67% to $0.37. The company's market cap stands at $64.4 million.
Forte Biosciences (NASDAQ:FBRX) shares declined by 9.77% to $0.44. The company's market cap stands at $15.9 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of its average volume over the last 100 days. The company's market cap stands at $57.8 million.
TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 11.24% to $0.58. At the close, TC BioPharm (Holdings)'s trading volume reached 265.9K shares. This is 294.2% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.
Nemaura Medical (NASDAQ:NMRD) shares rose 8.08% to $0.26. The company's market cap stands at $7.3 million.
Exagen (NASDAQ:XGN) stock moved upwards by 7.54% to $1.71. The market value of their outstanding shares is at $28.9 million.
NanoVibronix (NASDAQ:NAOV) shares rose 6.92% to $1.39. The market value of their outstanding shares is at $6.3 million.
Allarity Therapeutics (NASDAQ:ALLR) stock rose 6.0% to $0.53. The market value of their outstanding shares is at $2.2 million. As per the press release, Q3 earnings came out 4 days ago.

在週一的盤後交易中，NGM Biopharmaceuticals（納斯達克股票代碼：NGM）股價上漲11.5％，至0.7美元。該證券的交易量接近10.94萬股，佔過去100天平均交易量的23.4％。該公司的市值爲5,780萬美元。
TC BioPharm（控股）（納斯達克股票代碼：TCBP）股價上漲11.24％，至0.58美元。收盤時，TC BioPharm（控股）的交易量達到26.59萬股。這是其過去 100 天平均交易量的294.2％。該公司的市值爲540萬美元。
Nemaura Medical（納斯達克股票代碼：NMRD）股價上漲8.08％，至0.26美元。該公司的市值爲730萬美元。
Exagen（納斯達克股票代碼：XGN）股價上漲7.54％，至1.71美元。他們流通股的市值爲2890萬美元。
NanoVibronix（納斯達克股票代碼：NAOV）股價上漲6.92％，至1.39美元。他們流通股的市值爲630萬美元。
Allarity Therapeutics（納斯達克股票代碼：ALLR）股價上漲6.0％，至0.53美元。他們流通股的市值爲220萬美元。根據新聞稿，第三季度業績是在4天前發佈的。

Alzamend Neuro (NASDAQ:ALZN) shares decreased by 19.4% to $1.12 during Monday's after-market session. Alzamend Neuro's trading volume hit 2.7 million shares by close, accounting for 13294.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
Gain Therapeutics (NASDAQ:GANX) shares fell 16.37% to $2.3. The company's market cap stands at $29.2 million. As per the news, the Q3 earnings report came out 4 days ago.
Acutus Medical (NASDAQ:AFIB) shares declined by 16.04% to $0.29. Today's trading volume for this security ended up closing at 399.7K shares, which is 117.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
AVITA Medical (NASDAQ:RCEL) shares declined by 11.2% to $11.11. The market value of their outstanding shares is at $283.8 million.
Vicarious Surgical (NYSE:RBOT) stock decreased by 10.67% to $0.37. The company's market cap stands at $64.4 million.
Forte Biosciences (NASDAQ:FBRX) shares declined by 9.77% to $0.44. The company's market cap stands at $15.9 million. See Also:

在週一的盤後交易中，Alzamend Neuro（納斯達克股票代碼：ALZN）股價下跌19.4％，至1.12美元。Alzamend Neuro的交易量收盤時達到270萬股，佔其過去100天平均成交量的13294.1％。他們流通股的市值爲720萬美元。
Gain Therapeutics（納斯達克股票代碼：GANX）股價下跌16.37％，至2.3美元。該公司的市值爲2920萬美元。根據消息，第三季度收益報告是在4天前發佈的。
Acutus Medical（納斯達克股票代碼：AFIB）股價下跌16.04％，至0.29美元。該證券今天的交易量最終收於39.97萬股，佔其過去100天平均交易量的117.1％。他們流通股的市值爲840萬美元。
AVITA Medical（納斯達克股票代碼：RCEL）股價下跌11.2％，至11.11美元。他們流通股的市值爲2.838億美元。
Vicarious Surgical（紐約證券交易所代碼：RBOT）股價下跌10.67％，至0.37美元。該公司的市值爲6,440萬美元。
Forte Biosciences（納斯達克股票代碼：FBRX）股價下跌9.77％，至0.44美元。該公司的市值爲1,590萬美元。另見：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

風險及免責聲明